Takashi Fujita

About

Takashi Fujita is a leading urological researcher whose work centers on improving postoperative outcomes for prostate cancer patients, particularly following robot-assisted laparoscopic radical prostatectomy (RARP). His major contributions lie in understanding and predicting two critical complications: de novo overactive bladder (OAB) and long-term urinary incontinence. In a pivotal 2018 study, Fujita prospectively examined 245 patients without pre-existing OAB, identifying key factors that trigger storage symptoms after RARP—work that has garnered 38 citations and reshaped clinical awareness of this underrecognized issue. Expanding on this, his 2020 research on 315 patients demonstrated that daily urine loss immediately after catheter removal serves as a powerful, easily obtainable predictor of persistent incontinence, a finding that has earned 21 citations and offers surgeons a practical tool for early intervention. By translating complex postoperative data into actionable clinical metrics, Fujita has directly enhanced patient counseling and rehabilitation strategies. His work stands out for its methodological rigor and patient-centered focus, making him a respected voice in the effort to minimize the long-term quality-of-life impacts of prostate cancer surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   De novo overactive bladder after robot‐assisted laparoscopic radical prostatectomy

   38 citations · 2018
2. 2
   Daily urine loss immediately after urethral catheter removal may be an effective predictor of long-term urinary incontinence following robot-assisted laparoscopic radical prostatectomy

   21 citations · 2020
3. 3
   Daily urine loss immediately after urethral catheter removal may be an effective predictor of long‐term urinary incontinence following robot‐assisted laparoscopic radical prostatectomy

   3 citations · 2020

Key Collaborators

Contact & Links